Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Z Su

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Zhonghua Nei Ke Za Zhi|September 1, 1985
[Chemosensitivity assay in acute leukemia]Y Z Su, Q C Pan
Anticancer Research|March 1, 1992
Further characterization of two distinct adriamycin-resistant sublines from LoVo human colon carcinoma cellsL Y Yang, J M Trujillo, Y Z Su
European Review for Medical and Pharmacological Sciences|December 3, 2021
LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3pY-Z Su, M-F Cui, J Du, et al.
European Review for Medical and Pharmacological Sciences|February 26, 2020
LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3pY-Z Su, M-F Cui, J Du, et al.
Genetics and Molecular Research : GMR|July 1, 2015
Effects of changes in serum endostatin and fibroblast growth factor 19 on the chemotherapeutic sensitivity in acute myeloid leukemia patientsY Z Su, C B Wang, Y Zhou, et al.
Anticancer Research|January 1, 1991
Heterogeneous effects of interferon on antitumor agents' cytotoxicities to human colon carcinoma cell linesJ M Trujillo, L Y Yang, G Gercovich, et al.
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|December 1, 1983
[Structure-activity relationship of hexamethylmelamine derivatives]Y Z Su, Q C Pan, M Z Sun, et al.
Cancer Treatment Reports|June 1, 1987
Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasmsY Z Su, T E Duarte, P L Dill, et al.
Progress in Clinical and Biological Research|January 1, 1988
Non-clonogenic, in vitro assays for predicting sensitivity to cancer chemotherapyL M Weisenthal, Y Z Su, T E Duarte, et al.
Anticancer Research|November 1, 1989
Metronidazole enhances the cytotoxic synergism produced by the combination of 1-beta-arabinofuranosylcytosine and cis-diamminedichloroplatinumJ M Trujillo, L Y Yang, G Gercovich, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Zhonghua Nei Ke Za Zhi|September 1, 1985
[Chemosensitivity assay in acute leukemia]Y Z Su, Q C Pan
Anticancer Research|March 1, 1992
Further characterization of two distinct adriamycin-resistant sublines from LoVo human colon carcinoma cellsL Y Yang, J M Trujillo, Y Z Su
European Review for Medical and Pharmacological Sciences|December 3, 2021
LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3pY-Z Su, M-F Cui, J Du, et al.
European Review for Medical and Pharmacological Sciences|February 26, 2020
LncRNA DCST1-AS1 regulated cell proliferation, migration, invasion and apoptosis in gastric cancer by targeting miR-605-3pY-Z Su, M-F Cui, J Du, et al.
Genetics and Molecular Research : GMR|July 1, 2015
Effects of changes in serum endostatin and fibroblast growth factor 19 on the chemotherapeutic sensitivity in acute myeloid leukemia patientsY Z Su, C B Wang, Y Zhou, et al.
Anticancer Research|January 1, 1991
Heterogeneous effects of interferon on antitumor agents' cytotoxicities to human colon carcinoma cell linesJ M Trujillo, L Y Yang, G Gercovich, et al.
Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|December 1, 1983
[Structure-activity relationship of hexamethylmelamine derivatives]Y Z Su, Q C Pan, M Z Sun, et al.
Cancer Treatment Reports|June 1, 1987
Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasmsY Z Su, T E Duarte, P L Dill, et al.
Progress in Clinical and Biological Research|January 1, 1988
Non-clonogenic, in vitro assays for predicting sensitivity to cancer chemotherapyL M Weisenthal, Y Z Su, T E Duarte, et al.
Anticancer Research|November 1, 1989
Metronidazole enhances the cytotoxic synergism produced by the combination of 1-beta-arabinofuranosylcytosine and cis-diamminedichloroplatinumJ M Trujillo, L Y Yang, G Gercovich, et al.
Pageof 2